On July 31, 2019 Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics reported that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following investor conference (Press release, Five Prime Therapeutics, JUL 31, 2019, View Source [SID1234537961]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 2019 Wedbush PacGrow Healthcare Conference Wednesday, August 14, 2019 at 8:35am ET / 5:35am PT
The presentations will be webcast and may be accessed at the "Events & Presentations" section of the Company’s website at:

View Source Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.